ocgn sec filings

OCGN Stock: Ocugen Shorts Are Running for Cover. Feed of latest filings. 8-K: Current Reports. To visit the company's web site, go to ocugen.com. SPY 2. StreetInsider.com Top Tickers, 2/28/2021. report. Screening Tools New; Document Search; Table Tools; Collaboration; Organization; Other; Pricing; Contact; Log In; Free Trial; Ocugen Inc Watch . Touch device users, explore by touch or with swipe gestures. 4 Wall Street analysts have issued ratings and price targets for Ocugen in the last 12 months. The … Announces $23 Million Registered Direct Offering of Common Stock Priced at a Premium to Market. Long and … 117. Home; SEC Forms; Form 13F-HR; SEC Form 13F-HR. March 8, 2021 - 2:50 pm. SEC filings and transcripts for Ocugen Inc, including financials, news, proxies, indentures, prospectuses, and credit agreements . best. E-mail Address. Article Stock Quotes (1) FREE Breaking News Alerts from StreetInsider.com! The high price target for OCGN is $10.00 and the low price target for OCGN is $0.70. View my complete profile . News see full image. Log in or sign up to leave a comment Log In Sign Up. Ocugen Inc. SEC Filings. SEC Filings. XBRL. Covaxin Strong and Ocugen Long. HISTOGENICS : Ticker OCGN SEC Filings Histogenics Security and Exchange Commission filings. save. Official Site; Blogger; YouTube; … Visit OCGN's SEC page to see the company's official filings. OCGN: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: US Dollars: CIK Code: 1372299: CUSIP Number: 43358V109: ISIN Number: US67577C1053: Company Description. According to this SEC filing, OCGN CFO just purchased 35.5k shares of the company. Ocugen (NASDAQ:OCGN) SEC Filings. Items per page. 30 Days of MarketBeat All Access for $1.00. :DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No. Ocugen, Inc. (OCGN) SEC Filing 10-K Annual report for the fiscal year ending Tuesday, December 31, 2019. Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings) IRS No. Ocugen SEC Filing 03/05/21. Form 8-K Ocugen, Inc. For: Feb 02 . : 000000000 | State of Incorp. PDF HTML Audio Earnings Webcast. 61 comments. 0001104659-21-031198.xls. 0001104659-21-031198.rtf. BRIEF-Ocugen Inc Says Bharat Biotech Has Agreed To Provide A Specified Minimum Number Of Doses Of COVAXIN In … 13F filings are submitted quarterly to the SEC by hedge funds and other investment managers. Home SEC Filings Ocugen, Inc. (OCGN) 10-K Annual Report Fri … #Ocugreen⬆️. Related Documents. Find a Symbol When autocomplete results are available use up and down arrows to review and enter to select. OCGN Shares Results of Shareholder Vote. Recent 13D Filings for Ocugen, Inc. (OCGN) Since 2020, there have been 7 Schedule 13D forms (beneficial ownership report) filed for the company Ocugen, Inc. (stock symbol OCGN) by 4 beneficial owners. MALVERN, Pa., March 03, 2021 -- Ocugen, Inc. (OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that its co-development partner, Bharat Biotech, announced the results of the first interim analysis of its Phase 3 study of COVAXIN, a … 1. (Filer) Received ( Period ) PRE 14A. OCUGEN, INC. 02/11/21 (03/16/21) SC 13G. These and other risks and uncertainties are more fully described in our periodic filings with the SEC, including the risk factors described in the section entitled "Risk Factors" in the quarterly and annual reports that we file with the SEC. Ocgn Stock Symbol / OCGN Stock - Ocugen, Inc. SEC Filings : I`ve extended the fibonacci retracement tool to see the possible retracemet outcomes of this stock.. (ocgn) stock quote, history, news and other vital information to help you with your stock trading and tip: Markets us stocks health technology biotechnology. I just want to take a moment to thank everyone who has provided DD, encouraged others with kindness or brought a little humor on the rough days. ZIP XLS HTML. Log On Open an account. Companies; Documents; Forms; Alerts; Stock Ticker Lookup. OCGN Stock Price Chart Interactive Chart > OCGN Price/Volume Stats . These and other risks and uncertainties are more fully described in our periodic filings with the Securities and Exchange Commission (the "SEC"), including the risk factors described in the section entitled "Risk Factors" in the quarterly and annual reports that we file with the SEC. Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings) IRS No. PDF HTML. Ocugen Inc. sec form 4 filings insider trading, stock buying and selling. What a rollercoaster ride this has been! Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring. SEC Filings SEC Filings Group. Ocugen, Inc. is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. GlobeNewswire - 9:44 PM ET 02/07/2021. Long and … Posted by 7 hours ago. 10-K Filing. Any forward-looking statements that we make in this press release speak only as of the date of this press release. Real-time Insider Trading Stock Screener. Filings . SEC Filings for Ocugen Inc (OCGN) including Annual 10-K and Quarterly 10-Q Reports. 100% Upvoted. Annual report pursuant to Section 13 and 15(d) View PDF View HTML. 4 2020 Fiscal Year Results. HISTOGENICS : Ticker OCGN SEC Filings at 6:23 PM No comments: Email This BlogThis! A schedule 13D is filed when a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company's equity securities. #bullish. In order to access the Stocks SEC Filings, please log on to your TD Ameritrade account or open an account! Current price $8.74 : 52-week high $18.77 : Prev. Posted by just now. Real-time Insider Trading Stock Screener. According to this SEC filing, OCGN CFO just purchased 35.5k shares of the company. SEC Form 13F-HR Quarterly Report. Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Insider trades for Ocugen, Inc. (OCGN). As mentioned above, on December 28, 2020, Ocugen submitted a filing with the SEC surrounding the results of a shareholder vote. WhaleWisdom 13F Data. Ocugen Inc (NASDAQ: OCGN) is screaming for the top in the market this morning. Form Type: Ownership Filings: Date Filer Form Type View; This page was last updated on 1/25/2021 by MarketBeat.com Staff. Search / Go. The most recent transaction is an insider purchase by Castillo Kirsten, the company’s Director. Monitor SEC Form 4 Insider Trading Filings for Insider Buying and Selling. MALVERN, Pa., March 08, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it will present at the H.C. Wainwright Global Life Sciences Conference being held on … Toggle navigation. Filing year. CMTX - Tue Feb 2, 8:26AM CST. Filing date Description Form Filing Group Issuer View; Mar 03, 2021: Report of unscheduled material events or corporate event. Share to Twitter Share to Facebook Share to Pinterest. Features New. SEC Filings; Overview; All SEC Filings; Annual Reports; Quarterly Reports; Section 16 Filings; Latest Quarterly or Annual Filing March 2, 2021. Reuters - 9:46 PM ET 02/07/2021. Ocugen, Inc. SEC Filing - Proxy Statement (definitive) (DEF 14A) February 22, 2021 SEC Filings Mon, Feb. 22 COVID-19 vaccine developers to benefit from supply constraints and uneven distribution #bullish. View 13F filing holders of OCUGEN ORD SHS. OCGN : 9.18 (-10.61%) Ocugen and Bharat Biotech Announce Execution of Definitive Agreement for the Commercialization of COVAXIN (TM) in the US Market GlobeNewswire - Tue Feb 2, 8:26AM CST. Quarterly report filed by institutional managers, Holdings Search Full-Text of Form 13F-HR Search Metadata of Form 13F-HR. Ocugen, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of transformative therapies to cure blindness diseases. Older Posts Home. HISTOGENICS : Ticker OCGN SEC Filings. 61. save. : 000000000 | State of Incorp. Latest 10 SEC filings (by filing date) for OCGN within the last 6 months : Amended Filing Footnote and/or Remark: As of 11:59pm ET March 4th, 2021. :DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No. share. DD 0 comments. Duration of the delay for other exchanges varies. share. Monitor SEC Form 4 Insider Trading Filings for Insider Buying and Selling. Insider trades for Ocugen, Inc. (OCGN). DD Close. SEC filings show that Castillo Kirsten bought 75,000 shares of the company’s common stock on May 28 at a price of $0.31 per share for a total of $23498.0. Vote. Sort by. New SEC Filings. no comments yet. Ocugen, Inc. 0001104659-21-031198.pdf. close $8.97 : 52-week low $0.17 : Day low $7.48 : Volume 33,732,200 : Day high $9.34 : Avg. Earnings Release. Their average twelve-month price target is $4.80, predicting that the stock has a possible downside of 46.49%. Date Form Company; 2021-03-05 16:15:54: 13F-HR: CHIRON CAPITAL MANAGEMENT, LLC: … Subscribe to: Posts (Atom) About Me. hide. OCGN: The Nasdaq Stock Market LLC (The Nasdaq Capital Market) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 10-K. OCGN (Nasdaq Capital Market) Enter your Email to Learn More: Form. Ocugen Inc. (OCGN) Insider Activity.

Of Dogs Crossword Clue, Toolstation Work Shorts, Mayfield Dinner Theatre Ticket Prices, House And Lot For Sale In Baguio City Cheap, Dermovent 5 Cream Uses, St Margaret High School, Logstash Prometheus Output,